Puyi Biotech
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A Chinese genomics company developing NGS-based diagnostic tests for clinical applications like oncology and reproductive health.
Genetics & GenomicsOncologyDiagnostics
Technology Platform
A next-generation sequencing and bioinformatics platform for developing and offering genetic diagnostic tests for various clinical conditions.
Opportunities
The massive, under-penetrated Chinese clinical genetics market and supportive government policies for precision medicine offer significant growth potential.
Risk Factors
Risks include rapid technological obsolescence, potential regulatory changes, and intense price competition in the Chinese diagnostics landscape.
Competitive Landscape
Competes in China's crowded and competitive clinical genomics market, where scale, sales channels, and test accuracy are key differentiators.